Skip to content
2000
Volume 33, Issue 6
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Objective

Prior studies have associated vesicle-associated membrane protein-associated protein B (VAPB) with various cardiovascular diseases, yet its role in calcific Aortic Valve Disease (CAVD) is not fully understood. This study aims to elucidate the relationship between VAPB and aortic valve calcification at both tissue and cellular molecular levels, exploring potential regulatory mechanisms.

Methods

The expression levels of VAPB in calcified valve tissues were assessed using immunohistochemical analysis. Osteogenic differentiation and calcification levels of valve interstitial cells (VICs) were evaluated by alizarin red staining, calcium content quantification, and the detection of the osteogenic markers. Gene set enrichment analysis (GSEA) was used to identify downstream pathways regulated by VAPB, immunoblotting was used to detect the expression of key molecules of SMAD signaling, and immunoprecipitation was performed to detect interactions between VAPB and SMAD1/5/9.

Results

VAPB expression was significantly upregulated in the aortic valve leaflets of patients with CAVD. VICs with VAPB overexpression exhibited a significant increase in calcium content ( < 0.001) and upregulation of osteogenic markers RUNX2, osteocalcin, and osteopontin ( <0. 01). Conversely, VAPB knockdown reduced osteogenic differentiation in VICs. Furthermore, VAPB overexpression led to the enhanced expression of p-SMAD1/5/9 through activation of the SMAD signaling pathway ( < 0.05), while inhibition of the SMAD pathway abrogated the pro-calcification effects of VAPB. Dual immunofluorescence staining demonstrated colocalization of VAPB with SMAD1/5/9, and immunoprecipitation confirmed an interaction between VAPB and SMAD1/5/9.

Conclusion

The findings indicate that VAPB promotes osteogenic differentiation in aortic valve interstitial cells by activating the SMAD signaling pathway.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673355591250121085134
2025-02-07
2026-02-25

  • From This Site

    /content/journals/cmc/10.2174/0109298673355591250121085134
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. BonowR.O. LeonM.B. DoshiD. MoatN. Management strategies and future challenges for aortic valve disease.Lancet2016387100251312132310.1016/S0140‑6736(16)00586‑927025437
     [Google Scholar]
  2. BlaserM.C. KralerS. LüscherT.F. AikawaE. Multi-omics approaches to define calcific aortic valve disease pathogenesis.Circ. Res.202112891371139710.1161/CIRCRESAHA.120.31797933914608
     [Google Scholar]
  3. BoskovskiM.T. GleasonT.G. Current therapeutic options in aortic stenosis.Circ. Res.202112891398141710.1161/CIRCRESAHA.121.31804033914604
     [Google Scholar]
  4. PeetersF.E.C.M. MeexS.J.R. DweckM.R. AikawaE. CrijnsH.J.G.M. SchurgersL.J. KietselaerB.L.J.H. Calcific aortic valve stenosis: hard disease in the heart.Eur. Heart J.201839282618262410.1093/eurheartj/ehx65329136138
     [Google Scholar]
  5. TowlerD.A. Molecular and cellular aspects of calcific aortic valve disease.Circ. Res.2013113219820810.1161/CIRCRESAHA.113.30015523833294
     [Google Scholar]
  6. GoodyP.R. HosenM.R. ChristmannD. NiepmannS.T. ZietzerA. AdamM. BönnerF. ZimmerS. NickenigG. JansenF. Aortic valve stenosis.Arterioscler. Thromb. Vasc. Biol.202040488590010.1161/ATVBAHA.119.31306732160774
     [Google Scholar]
  7. WuH. CarvalhoP. VoeltzG.K. Here, there, and everywhere: the importance of er membrane contact sites.Science20183616401eaan583510.1126/science.aan583530072511
     [Google Scholar]
  8. KorsS. CostelloJ.L. SchraderM. Vap proteins – from organelle tethers to pathogenic host interactors and their role in neuronal disease.front. cell dev. biol.20221089585610.3389/fcell.2022.89585635756994
     [Google Scholar]
  9. De VosK.J. MórotzG.M. StoicaR. TudorE.L. LauK.F. AckerleyS. WarleyA. ShawC.E. MillerC.C.J. VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis.Hum. Mol. Genet.20122161299131110.1093/hmg/ddr55922131369
     [Google Scholar]
  10. ProsserD.C. TranD. GougeonP.Y. VerlyC. NgseeJ.K. FFAT rescues VAPA-mediated inhibition of ER-to- Golgi transport and VAPB-mediated ER aggregation.J. Cell Sci.2008121183052306110.1242/jcs.02869618713837
     [Google Scholar]
  11. PennettaG. HiesingerP.R. Fabian-FineR. MeinertzhagenI.A. BellenH.J. Drosophila VAP-33A directs bouton formation at neuromuscular junctions in a dosage-dependent manner.Neuron200235229130610.1016/S0896‑6273(02)00769‑912160747
     [Google Scholar]
  12. PerettiD. DahanN. ShimoniE. HirschbergK. LevS. Coordinated lipid transfer between the endoplasmic reticulum and the Golgi complex requires the VAP proteins and is essential for Golgi-mediated transport.Mol. Biol. Cell20081993871388410.1091/mbc.e08‑05‑049818614794
     [Google Scholar]
  13. MaoD. LinG. TepeB. ZuoZ. TanK.L. SenturkM. ZhangS. ArenkielB.R. SardielloM. BellenH.J. VAMP associated proteins are required for autophagic and lysosomal degradation by promoting a PtdIns4P-mediated endosomal pathway.Autophagy20191571214123310.1080/15548627.2019.158010330741620
     [Google Scholar]
  14. MontibellerL. TanL.Y. KimJ.K. PaulP. de BellerocheJ. Tissue-selective regulation of protein homeostasis and unfolded protein response signalling in sporadic ALS.J. Cell. Mol. Med.202024116055606910.1111/jcmm.1517032324341
     [Google Scholar]
  15. TripathiP. GuoH. DreserA. YamoahA. SechiA. JesseC.M. KatonaI. DoukasP. NikolinS. ErnstS. AronicaE. GlaßH. HermannA. SteinbuschH. FellerA.C. BergmannM. JaarsmaD. WeisJ. GoswamiA. Pathomechanisms of ALS8: altered autophagy and defective RNA binding protein (RBP) homeostasis due to the VAPB P56S mutation.Cell Death Dis.202112546610.1038/s41419‑021‑03710‑y33972508
     [Google Scholar]
  16. ZhaoY.G. LiuN. MiaoG. ChenY. ZhaoH. ZhangH. The ER contact proteins vapa/b interact with multiple autophagy proteins to modulate autophagosome biogenesis.Curr. Biol.201828812341245.e410.1016/j.cub.2018.03.00229628370
     [Google Scholar]
  17. JiangT. RuanN. LuoP. WangQ. WeiX. LiY. DaiY. LinL. LvJ. LiuY. ZhangC. Modulation of ER-mitochondria tethering complex VAPB-PTPIP51: Novel therapeutic targets for aging-associated diseases.Ageing Res. Rev.20249810232010.1016/j.arr.2024.10232038719161
     [Google Scholar]
  18. Martín-GuerreroS.M. MarkovinovicA. MórotzG.M. SalamS. NobleW. MillerC.C.J. Targeting ER-mitochondria signaling as a therapeutic target for frontotemporal dementia and related amyotrophic lateral sclerosis.Front. Cell Dev. Biol.20221091593110.3389/fcell.2022.91593135693938
     [Google Scholar]
  19. ChenJ. BassotA. GiulianiF. SimmenT. Amyotrophic lateral sclerosis (als): stressed by dysfunctional mitochondria-endoplasmic reticulum contacts (mercs).Cells2021107178910.3390/cells1007178934359958
     [Google Scholar]
  20. BorgeseN. IacominoN. ColomboS.F. NavoneF. The link between vapb loss of function and amyotrophic lateral sclerosis.Cells2021108186510.3390/cells1008186534440634
     [Google Scholar]
  21. LauD.H.W. PaillussonS. HartoppN. RupawalaH. MórotzG.M. Gomez-SuagaP. GreigJ. TroakesC. NobleW. MillerC.C.J. Disruption of endoplasmic reticulum-mitochondria tethering proteins in post-mortem Alzheimer’s disease brain.Neurobiol. Dis.202014310502010.1016/j.nbd.2020.10502032682953
     [Google Scholar]
  22. PaillussonS. Gomez-SuagaP. StoicaR. LittleD. GissenP. DevineM.J. NobleW. HangerD.P. MillerC.C.J. α-Synuclein binds to the ER–mitochondria tethering protein VAPB to disrupt Ca2+ homeostasis and mitochondrial ATP production.Acta Neuropathol.2017134112914910.1007/s00401‑017‑1704‑z28337542
     [Google Scholar]
  23. QiaoX. JiaS. YeJ. FangX. ZhangC. CaoY. XuC. ZhaoL. ZhuY. WangL. ZhengM. PTPIP51 regulates mouse cardiac ischemia/reperfusion through mediating the mitochondria-SR junction.Sci. Rep.2017714537910.1038/srep4537928345618
     [Google Scholar]
  24. Gomez-StallonsM.V. Wirrig-SchwendemanE.E. HasselK.R. ConwayS.J. YutzeyK.E. Bone morphogenetic protein signaling is required for aortic valve calcification.Arterioscler. Thromb. Vasc. Biol.20163671398140510.1161/ATVBAHA.116.30752627199449
     [Google Scholar]
  25. SongR. FullertonD.A. AoL. ZhaoK. MengX. An epigenetic regulatory loop controls pro-osteogenic activation by TGF-β1 or bone morphogenetic protein 2 in human aortic valve interstitial cells.J. Biol. Chem.2017292218657866610.1074/jbc.M117.78330828377507
     [Google Scholar]
  26. WangY. GuJ. DuA. ZhangS. DengM. ZhaoR. LuY. JiY. ShaoY. SunW. KongX. SPARC-related modular calcium binding 1 regulates aortic valve calcification by disrupting BMPR-II/p-p38 signalling.Cardiovasc. Res.2022118391392810.1093/cvr/cvab10733757126
     [Google Scholar]
  27. Duarte LauF. GiuglianoR.P. Lipoprotein(a) and its significance in cardiovascular disease.JAMA Cardiol.20227776076910.1001/jamacardio.2022.098735583875
     [Google Scholar]
  28. EleidM.F. NkomoV.T. PislaruS.V. GershB.J. Valvular heart disease: new concepts in pathophysiology and therapeutic approaches.Annu. Rev. Med.202374115517010.1146/annurev‑med‑042921‑12253336400067
     [Google Scholar]
  29. BamanJ.R. MedhekarA.N. MalaisrieS.C. McCarthyP. DavidsonC.J. BonowR.O. Management challenges in patients younger than 65 years with severe aortic valve disease.JAMA Cardiol.20238328128910.1001/jamacardio.2022.477036542365
     [Google Scholar]
  30. MonclaL.H.M. BriendM. BosséY. MathieuP. Calcific aortic valve disease: mechanisms, prevention and treatment.Nat. Rev. Cardiol.202320854655910.1038/s41569‑023‑00845‑736829083
     [Google Scholar]
  31. NazarzadehM. Pinho-GomesA.C. BidelZ. DehghanA. CanoyD. HassaineA. Ayala SolaresJ.R. Salimi-KhorshidiG. SmithG.D. OttoC.M. RahimiK. Plasma lipids and risk of aortic valve stenosis: a Mendelian randomization study.Eur. Heart J.202041403913392010.1093/eurheartj/ehaa07032076698
     [Google Scholar]
  32. PanW. HuangQ. ZhouL. LinJ. DuX. QianX. JiangT. ChenW. Epigenetic age acceleration and risk of aortic valve stenosis: a bidirectional Mendelian randomization study.Clin. Epigenetics20241614110.1186/s13148‑024‑01647‑538475866
     [Google Scholar]
  33. KimM.S. KimW.J. KheraA.V. KimJ.Y. YonD.K. LeeS.W. ShinJ.I. WonH.H. Association between adiposity and cardiovascular outcomes: an umbrella review and meta-analysis of observational and Mendelian randomization studies.Eur. Heart J.202142343388340310.1093/eurheartj/ehab45434333589
     [Google Scholar]
  34. DriscollK. CruzA.D. ButcherJ.T. Inflammatory and biomechanical drivers of endothelial-interstitial interactions in calcific aortic valve disease.Circ. Res.202112891344137010.1161/CIRCRESAHA.121.31801133914601
     [Google Scholar]
  35. GreenbergH.Z.E. ZhaoG. ShahA.M. ZhangM. Role of oxidative stress in calcific aortic valve disease and its therapeutic implications.Cardiovasc. Res.202211861433145110.1093/cvr/cvab14233881501
     [Google Scholar]
  36. TastetL. GénéreuxP. BernardJ. PibarotP. The role of extravalvular cardiac damage staging in aortic valve disease management.Can. J. Cardiol.20213771004101510.1016/j.cjca.2021.01.02033539990
     [Google Scholar]
  37. LiuX. LiT. SunJ. WangZ. The role of endoplasmic reticulum stress in calcific aortic valve disease.Can. J. Cardiol.202339111571158010.1016/j.cjca.2023.07.02537516250
     [Google Scholar]
  38. ObaraC.J. Nixon-AbellJ. MooreA.S. RiccioF. HoffmanD.P. ShtengelG. XuC.S. SchaeferK. PasolliH.A. MassonJ.B. HessH.F. CalderonC.P. BlackstoneC. Lippincott-SchwartzJ. Motion of VAPB molecules reveals ER–mitochondria contact site subdomains.Nature2024626799716917610.1038/s41586‑023‑06956‑y38267577
     [Google Scholar]
  39. ChoiS.W. YeonJ.T. ParkK.I. LeeC.H. YounB.S. OhJ. LeeM.S. VapB as a regulator of osteoclastogenesis via modulation of PLCγ2-Ca 2+ -NFAT signaling.FEBS Lett.2012586326326910.1016/j.febslet.2011.12.03322245675
     [Google Scholar]
  40. HuH. WangD. LiL. YinH. HeG. ZhangY. Role of microRNA-335 carried by bone marrow mesenchymal stem cells-derived extracellular vesicles in bone fracture recovery.Cell Death Dis.202112215610.1038/s41419‑021‑03430‑333542183
     [Google Scholar]
  41. WirrigE.E. YutzeyK.E. Conserved transcriptional regulatory mechanisms in aortic valve development and disease.Arterioscler. Thromb. Vasc. Biol.201434473774110.1161/ATVBAHA.113.30207124665126
     [Google Scholar]
  42. TóthA. BaloghE. JeneyV. Regulation of vascular calcification by reactive oxygen species.Antioxidants202091096310.3390/antiox910096333049989
     [Google Scholar]
  43. LeopoldJ.A. Cellular mechanisms of aortic valve calcification.Circ. Cardiovasc. Interv.20125460561410.1161/CIRCINTERVENTIONS.112.97102822896576
     [Google Scholar]
  44. WuM. WuS. ChenW. LiY.P. The roles and regulatory mechanisms of TGF-β and BMP signaling in bone and cartilage development, homeostasis and disease.Cell Res.202434210112310.1038/s41422‑023‑00918‑938267638
     [Google Scholar]
  45. DengZ. FanT. XiaoC. TianH. ZhengY. LiC. HeJ. TGF-β signaling in health, disease and therapeutics.Signal Transduct. Target. Ther.2024916110.1038/s41392‑024‑01764‑w38514615
     [Google Scholar]
  46. RatnaparkhiA. LawlessG.M. SchweizerF.E. GolshaniP. JacksonG.R. A Drosophila model of ALS: Human ALS-associated mutation in VAP33A suggests a dominant negative mechanism.PLoS One200836e233410.1371/journal.pone.000233418523548
     [Google Scholar]
/content/journals/cmc/10.2174/0109298673355591250121085134
Loading
VAPB Promotes Osteogenic Differentiation in Aortic Valve Interstitial Cells via Activation of the SMAD Signaling Pathway
Curr. Med. Chem. 33, 1249 (2026); https://doi.org/10.2174/0109298673355591250121085134
/content/journals/cmc/10.2174/0109298673355591250121085134
/content/journals/cmc/10.2174/0109298673355591250121085134
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): Calcific aortic valve disease; osteogenic differentiation; osteopontin; SMAD signaling; valvular interstitial cells; VAPB

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test